The Carlos Correa saga may finally be coming to an end, but it does not appear to be ending in the Mets’ favor.
According to ESPN, the shortstop has a deal in place with the Minnesota Twins for a six-year, $200 million contract pending a physical. The physical is once again key, as deals for the 28-year-old have fallen through with the San Francisco Giants and the Mets in recent weeks because of concerns spotted on the physical.
The Twins know Correa’s body better than most, having medically cleared him to finalize a three-year contract last March. They also conducted exit medical exams following the 2022 season. Correa opted out of the final two years of his contract to become a free agent.
The Mets and Correa had a deal in place for a 12-year, $315 million contract that came together late in the night of Dec. 20, just hours after negotiations fell through with the Giants for a 13-year, $350 million contract.
The concerns stem from the surgery he underwent to repair a fracture fibula and minor ligament damage in 2014. Teams cannot disclose the results of medical examinations, but sports orthopedic specialist Dr. Laith Jazrawi of NYU Langone recently told the Daily News what the clubs likely found was post-traumatic arthritis and cartilage damage, which could necessitate surgery within 5-10 years.
Correa, a two-time All-Star and the 2015 AL Rookie of the Year has never missed time at the Major League level with a right leg or ankle injury.
This is a developing story. Check back for details.